Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands. (14th December 2010)

• Record Type: Journal Article
• Authors: Penate Medina, Oula; Haikola, Merja; Tahtinen, Marja; Simpura, Ilkka; Kaukinen, Sami; Valtanen, Heli; Zhu, Ying; Kuosmanen, Sari; Cao, Wei; Reunanen, Justus; Nurminen, Tuula; Saris, Per E. J.; Smith-Jones, Peter; Bradbury, Michelle; Larson, Steven; Kairemo, Kalevi
• Other Names: Antimisiaris Sophia Academic Editor.
• Is Part Of: Journal of drug delivery. Volume 2011(2011)
• Publication Date: 2010-12-14
• Subjects: Drug delivery systems -- Periodicals; 615.605
• DOI: 10.1155/2011/160515
• Languages: English
• ISSNs: 2090-3014

Abstract

Abstract : Nanotechnology offers an alternative to conventional treatment options by enabling different drug delivery and controlled-release delivery strategies. Liposomes being especially biodegradable and in most cases essentially nontoxic offer a versatile platform for several different delivery approaches that can potentially enhance the delivery and targeting of therapies to tumors. Liposomes penetrate tumors spontaneously as a result of fenestrated blood vessels within tumors, leading to known enhanced permeability and subsequent drug retention effects. In addition, liposomes can be used to carry radioactive moieties, such as radiotracers, which can be bound at multiple locations within liposomes, making them attractive carriers for molecular imaging applications. Phage display is a technique that can deliver various high-affinity and selectivity peptides to different targets. In this study, gelatinase-binding peptides, found by phage display, were attached to liposomes by covalent peptide-PEG-PE anchor creating a targeted drug delivery vehicle. Gelatinases as extracellular targets for tumor targeting offer a viable alternative for tumor targeting. Our findings show that targeted drug delivery is more efficient than non-targeted drug delivery.